Who invested in Kronos Bio?
Kronos Bio's investors include Omega Funds, Norbert Bischofberger, Vida Ventures, Google Ventures and Polaris Partners, and 7 more on record. Omega Funds led its latest round.
United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$123Mraised across 2 rounds since 2018, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $105M sold, first sale Jul 2019
Reported by VcnewsdailySEC filing: $18M sold, first sale May 2018
From the SEC filings it signed: 4 on the team.
On the board, as filediArie S. BelldegrunJacob C. LovenJohn C. MartinJoshua A. KazamOtello C. StampacchiaRebecka C. Belldegrun
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Kronos Bio's investors include Omega Funds, Norbert Bischofberger, Vida Ventures, Google Ventures and Polaris Partners, and 7 more on record. Omega Funds led its latest round.
Kronos Bio has raised $123M across 2 rounds since 2018.
Kronos Bio's most recent round was a Series A of $105M in Jul 2019, led by Omega Funds.
Its most recent round, $105M in Jul 2019, is also its largest on record.
Kronos Bio's first round on record, in May 2018, was backed by Omega Funds, VIDA and Norbert Bischofberger and 2 others.
Kronos Bio's latest named round is a Series A, in Jul 2019.
Kronos Bio is based in the United States.
Omega Funds led the Series A in 2019.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.